Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

CareRx Corp

Healthcare CA CRRX

3.32CAD
0.07(2.15%)

Last update at 2026-06-23T19:53:00Z

Day Range

3.253.35
LowHigh

52 Week Range

2.473.98
LowHigh

Fundamentals

  • Previous Close 3.25
  • Market Cap234.61M
  • Volume35435
  • P/E Ratio9.12
  • Dividend Yield1.04%
  • EBITDA25.54M
  • Revenue TTM370.24M
  • Revenue Per Share TTM5.90
  • Gross Profit TTM 110.96M
  • Diluted EPS TTM0.41

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 3.35M -4.46900M -9.59500M -35.89600M -23.73500M
Minority interest - - - - -
Net income 26.13M -4.50100M -5.40500M -34.35300M -22.73000M
Selling general administrative 34.23M 32.75M 30.66M 34.43M 25.13M
Selling and marketing expenses - - 46.83M - -
Gross profit 92.63M 108.06M 84.72M 109.93M 75.28M
Reconciled depreciation 18.33M 19.19M 19.98M 20.07M 15.39M
Ebit 11.88M 4.71M 4.67M 7.91M 4.71M
Ebitda 30.22M 23.90M 24.65M 27.98M 20.11M
Depreciation and amortization 18.33M 19.19M 19.98M 20.07M 15.39M
Non operating income net other - - - - -
Operating income 11.88M 4.53M 4.67M 7.91M 4.71M
Other operating expenses 358.36M 362.19M 366.08M 374.09M 257.82M
Interest expense 6.84M 9.18M 14.27M 15.22M 14.49M
Tax provision -22.77400M 0.03M -4.19000M -1.54300M -1.00500M
Interest income 0.16M 9.12M 1.26M 0.28M 16.83M
Net interest income -6.68300M -9.11900M -13.01300M -14.94300M -14.58900M
Extraordinary items - - - - 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense -22.77400M 0.03M -4.19000M -1.54300M -1.00500M
Total revenue 370.24M 366.71M 370.75M 381.73M 262.63M
Total operating expenses 80.75M 103.53M 100.03M 102.30M 70.47M
Cost of revenue 277.61M 258.65M 286.02M 271.79M 187.35M
Total other income expense net -8.53000M -8.99400M -14.26500M -43.80700M -28.44900M
Discontinued operations - - - - -
Net income from continuing ops 26.13M -4.50100M -5.40500M -34.35300M -22.73000M
Net income applicable to common shares - -4.50100M -5.40500M -34.35300M -22.73000M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 253.02M 223.54M 231.89M 264.54M 282.82M
Intangible assets 28.89M 34.30M 44.33M 52.95M 54.57M
Earning assets - - - - -
Other current assets 2.17M 1.95M 1.96M 2.56M 3.52M
Total liab 143.51M 139.31M 150.37M 200.08M 200.53M
Total stockholder equity 109.50M 84.23M 81.53M 64.46M 82.29M
Deferred long term liab - - - - -
Other current liab 20.51M 1.19M 20.97M 23.40M 18.50M
Common stock 332.49M - 323.30M 299.78M 283.46M
Capital stock 332.49M 331.11M 323.30M 299.78M 283.46M
Retained earnings -263.57800M -287.18900M -282.68800M -277.28300M -242.93000M
Other liab - - - 10.97M 17.39M
Good will 70.01M 70.01M 70.01M 70.01M 92.11M
Other assets - - - - -
Cash 14.40M 9.08M 7.71M 28.37M 35.62M
Cash and equivalents - - - 28.37M 35.62M
Total current liabilities 63.03M 62.80M 62.45M 63.89M 52.97M
Current deferred revenue 0.76M - - - -
Net debt 63.53M 36.20M 89.81M 106.85M 89.95M
Short term debt 7.87M - 12.37M 10.01M 1.27M
Short long term debt 5.10M 5.33M 9.92M 7.41M 0.73M
Short long term debt total 77.92M - 97.52M 135.22M 125.57M
Other stockholder equity 40.59M - 33.62M 41.96M 41.76M
Property plant equipment - - - 52.39M 38.17M
Total current assets 67.02M 62.34M 65.41M 89.18M 95.25M
Long term investments - - - 0.00000M 2.71M
Net tangible assets - - - -58.50900M -64.40000M
Short term investments - - - - -
Net receivables 32.90M 32.43M 36.09M 37.26M 38.11M
Long term debt 35.96M 39.96M 57.15M 99.37M 111.97M
Inventory 17.55M 17.67M 19.66M 20.30M 17.99M
Accounts payable 33.89M 31.83M 29.11M 30.48M 33.21M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - 7.30M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 186.00M 161.20M 166.48M 175.36M 187.57M
Capital lease obligations 36.86M 37.34M 30.79M 28.44M 18.73M
Long term debt total - - - 125.22M 130.16M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -7.91800M -12.31400M -16.59800M -93.17700M
Change to liabilities - - - 0.82M 15.00M
Total cashflows from investing activities -8.25900M -7.91800M -12.31400M -16.59800M -93.17700M
Net borrowings -10.95800M -21.58200M -39.82400M -5.28900M 30.35M
Total cash from financing activities -14.44200M -28.01800M -36.40300M -12.98900M 101.91M
Change to operating activities - - - 0.31M -5.16900M
Net income 26.13M -4.50100M -5.40500M -34.35300M -22.73000M
Change in cash 4.83M 2.06M -21.34200M -7.25400M 16.00M
Begin period cash flow 9.56M 7.03M 29.05M 35.62M 19.62M
End period cash flow 14.40M 9.08M 7.71M 28.37M 35.62M
Total cash from operating activities 27.54M 37.99M 27.38M 22.33M 7.27M
Issuance of capital stock 0.01M 0.00000M 14.68M 1.01M 80.86M
Depreciation 18.33M 19.19M 19.98M 20.07M 15.39M
Other cashflows from investing activities - -2.52600M -3.92800M -2.98500M -86.06100M
Dividends paid 1.26M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory -0.12600M 1.55M 0.65M -1.99700M -2.83300M
Change to account receivables 0.25M 3.82M 1.47M 1.51M -10.72100M
Sale purchase of stock -2.23900M -0.80100M -0.05600M 1.01M 80.86M
Other cashflows from financing activities -7.89900M -5.63500M -11.20200M -8.70700M 51.69M
Change to netincome - - - 35.98M 18.33M
Capital expenditures 5.58M 8.11M 8.70M 13.61M 7.12M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.98800M 8.98M 2.12M 0.64M -3.72700M
Stock based compensation 2.71M 3.65M 1.47M 4.57M 2.67M
Other non cash items -15.93600M 10.64M 13.40M 32.96M 16.67M
Free cash flow 21.95M 29.88M 18.68M 8.72M 0.15M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CRRX
CareRx Corp		 0.07 2.15% 3.32 9.12 21.37 0.63 2.14 0.81 10.47
EXE
Extendicare Inc		 0.08 0.23% 34.13 25.21 23.92 1.59 7.26 1.62 14.43
SIA
Sienna Senior Living Inc		 0.45 2.08% 22.04 45.94 38.17 2.23 3.17 3.57 21.90
WELL
WELL Health Technologies Corp		 0.02 0.49% 4.13 - 13.87 0.80 1.23 1.09 9.83
DR
Medical Facilities Corporation		 0.04 0.22% 18.09 15.57 12.94 1.18 2.87 0.92 3.64

Reports Covered

Stock Research & News

View All

Profile

CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company also offers medication management services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada.

CareRx Corp

320 Bay Street, Toronto, ON, Canada, M5H 4A6

Key Executives

Name Title Year Born
Mr. David Murphy Pres, CEO & Director NA
Mr. Andrew Mok Chief Financial Officer NA
Mr. Puneet Khanna Chief Operating Officer NA
Mr. Paul Rakowski Sr. VP of Corp. Devel., Gen. Counsel, Chief Privacy Officer and Corp. Sec. NA
Ms. Adrianne Sullivan Campeau Chief People & Culture Officer NA
Mr. Ryan Stempfle VP & GM of Western Canada for the Specialty Pharmacy Division NA
Mr. Puneet Khanna CEO, President & Director NA
Mr. Paul Rakowski Senior VP of Corporate Development, General Counsel, Chief Privacy Officer & Corporate Secretary NA
Mr. Travis Featherstone Senior VP of Western Operations & System Integration NA
Ms. Suzanne Brand Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.